The life sciences firm informed customers in an email this week that it is increasing the list prices for its molecular and protein biology products, Applied Biosystems, Invitrogen, Gibco and Ion Torrent products, as of January 1 2018.
“We have endeavoured to keep increases to a minimum to limit any impact on you and your research and although increases have been unavoidable in some areas, a proportion of our portfolio remains unchanged or will even decrease, helping you to stretch your budget even further,” the firm said.
It also warned freight pricing will also increase, and the updated list prices may change further “due to market conditions,” and suggested customers “place any pending orders before December 31, 2017 to take advantage of the current 2017 List Prices.”
Thermo Fisher did not respond to a request for comment from Biopharma-Reporter, but according to its FAQs the price increases differ across different products but averages to a 3.3% rise on current prices.
“The list price changes and effective dates take into account the changing market conditions including currency fluctuations, inflation rate changes and other business costs. This change is required so that we remain competitive in the market, continuing to provide a high value offering, whilst managing the associated costs of doing business and retaining high levels of service and quality.”
Thermo Fisher’s molecular and protein biology products include protein expression, assays and analysis, and purification and isolation tools and consumables. Applied Biosystems includes instruments and reagents used for sequencing, flow cytometry, and real-time, digital and end point PCR.
The Invitrogen range offers equipment and services for genetic engineering, amplification, purification, quantification and analysis. Gibco includes a range of media, supplements, cells, and cell culture reagents.
Meanwhile Ion Torrent offers next-generation sequencing, and was added to Thermo Fisher’s portfolio through the acquisition of Life Technologies in 2014.